{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:40Z","timestamp":1790983120374,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Guillain-Barr\u00e9 syndrome (GBS) is an acute immune-mediated polyneuropathy characterised by rapidly progressive weakness, sensory disturbance, and autonomic dysfunction, often requiring intensive supportive care. While most cases follow gastrointestinal or respiratory infections, rare cases have been reported after vaccination. A 72-year-old man developed progressive symmetrical weakness and areflexia three weeks after receiving an mRNA COVID-19 vaccine. His condition deteriorated to bulbar dysfunction and respiratory failure, requiring intubation, tracheostomy, and prolonged ventilatory support. Cerebrospinal fluid analysis demonstrated albuminocytologic dissociation, while neuroimaging excluded structural pathology. Intravenous immunoglobulin was initiated promptly, followed by intensive multidisciplinary rehabilitation, including hydrotherapy. He gradually improved, was successfully decannulated, and transferred to a rehabilitation facility. This case highlights a rare possible post-vaccination association while emphasising that causality remains uncertain. Early recognition, close respiratory monitoring, and comprehensive rehabilitation are essential, as meaningful recovery is achievable even after severe disease.<\/jats:p>","DOI":"10.1093\/omcr\/omag153","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:55:52Z","timestamp":1785412552000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Guillain-Barr\u00e9 syndrome after mRNA COVID-19 vaccination with rapid deterioration and recovery: a case report"],"prefix":"10.1093","volume":"2026","author":[{"given":"Raees","family":"Samli","sequence":"first","affiliation":[{"name":"Department of Medicine, Royal Blackburn Hospital, East Lancashire Hospitals NHS Trust , Haslingden Road, Blackburn, BB2 3HH England ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bara\u2019a","family":"Al-Diri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Blackburn Hospital, East Lancashire Hospitals NHS Trust , Haslingden Road, Blackburn, BB2 3HH England ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-9824","authenticated-orcid":false,"given":"Eyad","family":"Jamileh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal Blackburn Hospital, East Lancashire Hospitals NHS Trust , Haslingden Road, Blackburn, BB2 3HH England ,","place":["United Kingdom"]},{"name":"School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast , University Road, Belfast BT9 7BL, Northern Ireland ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghread","family":"Hudaib","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Lincoln , Brayford Pool, Lincoln, LN6 7TS, England ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026082207314287000_ref1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.7861\/clinmedicine.10-4-399","article-title":"Guillain-Barr\u00e9 syndrome","volume":"10","author":"Pritchard","year":"2010","journal-title":"Clin Med"},{"key":"2026082207314287000_ref2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"2026082207314287000_ref3","doi-asserted-by":"publisher","first-page":"e2253845","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026082207314287000_ref4","doi-asserted-by":"publisher","first-page":"11795476241274692","DOI":"10.1177\/11795476241274692","article-title":"A death for Guillain-Barr\u00e8 syndrome after receiving a COVID-19 vaccine: a case report","volume":"17","author":"Coviello","year":"2024","journal-title":"Clin Med Insights Case Rep"},{"key":"2026082207314287000_ref5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"key":"2026082207314287000_ref6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain J Neurol"},{"key":"2026082207314287000_ref7","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1007\/s00415-021-10479-9","article-title":"Cerebrospinal fluid analysis in Guillain\u2013Barr\u00e9 syndrome: value of albumin quotients","volume":"268","author":"Rath","year":"2021","journal-title":"J Neurol"},{"key":"2026082207314287000_ref8","doi-asserted-by":"publisher","first-page":"CD002063","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026082207314287000_ref9","doi-asserted-by":"publisher","first-page":"e2094","DOI":"10.1212\/WNL.0000000000207847","article-title":"Risk of Guillain-Barr\u00e9 syndrome following COVID-19 vaccines","volume":"101","author":"Le Vu","year":"2023","journal-title":"Neurology."},{"key":"2026082207314287000_ref10","doi-asserted-by":"publisher","first-page":"e04756","DOI":"10.1002\/ccr3.4756","article-title":"COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect","volume":"9","author":"Matarneh","year":"2021","journal-title":"Clin Case Reports"},{"key":"2026082207314287000_ref11","doi-asserted-by":"publisher","first-page":"e169111637292","DOI":"10.33448\/rsd-v11i16.37292","article-title":"Silva B de O da: Os Efeitos da hidroterapia na S\u00edndrome de Guillain-Barr\u00e9 p\u00f3s vacina\u00e7\u00e3o contra Covid-19: Relato de Caso. Res","volume":"11","author":"Santos","year":"2022","journal-title":"Soc Dev"},{"key":"2026082207314287000_ref12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jns.12484","article-title":"Variations within toll-like receptor (TLR) and TLR signaling pathway-related genes and their synergistic effects on the risk of Guillain-Barr\u00e9 syndrome","volume":"27","author":"Dutta","year":"2022","journal-title":"J Peripher Nerv Syst"},{"key":"2026082207314287000_ref13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s41983-021-00310-7","article-title":"Guillain-Barre syndrome in 220 patients with COVID-19","volume":"57","author":"Finsterer","year":"2021","journal-title":"Egypt J Neurol Psychiatry Neurosurg"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2026\/8\/omag153\/70610981\/omag153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2026\/8\/omag153\/70610981\/omag153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:31:47Z","timestamp":1787398307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omag153\/8758926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omag153","relation":{},"ISSN":["2053-8855"],"issn-type":[{"value":"2053-8855","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"omag153"}}